Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Otorhinolaryngology

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 45 articles:
HTML format
Text format



Single Articles


    December 2018
  1. JIANG C, Wang H, Xia C, Dong Q, et al
    A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma.
    Cancer. 2018 Dec 6. doi: 10.1002/cncr.31907.
    PubMed     Text format     Abstract available


  2. BADR H, Herbert K, Chhabria K, Sandulache VC, et al
    Self-management intervention for head and neck cancer couples: Results of a randomized pilot trial.
    Cancer. 2018 Dec 6. doi: 10.1002/cncr.31906.
    PubMed     Text format     Abstract available


    November 2018
  3. CRACCHIOLO JR, Klassen AF, Young-Afat DA, Albornoz CR, et al
    Leveraging patient-reported outcomes data to inform oncology clinical decision making: Introducing the FACE-Q head and neck cancer module.
    Cancer. 2018 Nov 30. doi: 10.1002/cncr.31900.
    PubMed     Text format     Abstract available


  4. EYTAN DF, Blackford AL, Eisele DW, Fakhry C, et al
    Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.
    Cancer. 2018 Nov 16. doi: 10.1002/cncr.31800.
    PubMed     Text format     Abstract available


  5. GREALLY M, Ilson DH
    Neoadjuvant therapy for esophageal cancer: Who, when, and what?
    Cancer. 2018;124:4276-4278.
    PubMed     Text format    


    October 2018
  6. HARADA K, Pool Pizzi M, Baba H, Shanbhag ND, et al
    Cancer stem cells in esophageal cancer and response to therapy.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31697.
    PubMed     Text format    


  7. GUO R, Tang LL, Mao YP, Du XJ, et al
    Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
    Cancer. 2018 Oct 23. doi: 10.1002/cncr.31741.
    PubMed     Text format     Abstract available


  8. THAM T
    Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: Multicenter study from an endemic area in Southern China.
    Cancer. 2018 Oct 21. doi: 10.1002/cncr.31819.
    PubMed     Text format    


  9. CHAN JYW, Huang WB, Liu DL
    Reply to Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: multicenter study from an endemic area in Southern China.
    Cancer. 2018 Oct 21. doi: 10.1002/cncr.31815.
    PubMed     Text format    


  10. BAUML JM, Vinnakota R, Anna Park YH, Bates SE, et al
    Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of veterans health affairs data.
    Cancer. 2018 Oct 20. doi: 10.1002/cncr.31816.
    PubMed     Text format     Abstract available


  11. XIANG M, Holsinger FC, Colevas AD, Chen MM, et al
    Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results-Medicare analysis.
    Cancer. 2018 Oct 17. doi: 10.1002/cncr.31708.
    PubMed     Text format     Abstract available


  12. BAUMAN JE, Duvvuri U, Thomas S, Gooding WE, et al
    Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives.
    Cancer. 2018 Oct 6. doi: 10.1002/cncr.31651.
    PubMed     Text format     Abstract available


  13. SABA NF, Mendenhall WM, Hutcheson K, Suarez C, et al
    Salvage Surgery for Squamous Cell Carcinoma of the Head and Neck in the Era of Immunotherapy: Is It Time to Clarify Our Guidelines?
    Cancer. 2018 Oct 5. doi: 10.1002/cncr.31717.
    PubMed     Text format    


    August 2018
  14. SARAFIM-SILVA BAM, Duarte GD, Sundefeld MLMM, Biasoli ER, et al
    Childhood Trauma Is Predictive for Clinical Staging, Alcohol Consumption, and Emotional Symptoms in Patients With Head and Neck Cancer.
    Cancer. 2018 Aug 6. doi: 10.1002/cncr.31597.
    PubMed     Text format     Abstract available


    June 2018
  15. GRABOYES EM, Ellis MA, Li H, Kaczmar JM, et al
    Racial and ethnic disparities in travel for head and neck cancer treatment and the impact of travel distance on survival.
    Cancer. 2018 Jun 22. doi: 10.1002/cncr.31571.
    PubMed     Text format     Abstract available


    May 2018
  16. SOTO-PEREZ-DE-CELIS E, Sun CL, Tew WP, Mohile SG, et al
    Association between patient-reported hearing and visual impairments and functional, psychological, and cognitive status among older adults with cancer.
    Cancer. 2018 May 24. doi: 10.1002/cncr.31540.
    PubMed     Text format     Abstract available


  17. XIAO C, Beitler JJ, Higgins KA, Glazer T, et al
    Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer.
    Cancer. 2018 May 9. doi: 10.1002/cncr.31537.
    PubMed     Text format     Abstract available


  18. HO AS, Kim S, Tighiouart M, Mita A, et al
    Quantitative survival impact of composite treatment delays in head and neck cancer.
    Cancer. 2018 May 9. doi: 10.1002/cncr.31533.
    PubMed     Text format     Abstract available


  19. WEISS JM, Grilley-Olson JE, Deal AM, Zevallos JP, et al
    Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck.
    Cancer. 2018 May 9. doi: 10.1002/cncr.31526.
    PubMed     Text format     Abstract available


    April 2018
  20. GUERRIERO MK, Redman MW, Baker KK, Martins RG, et al
    Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial.
    Cancer. 2018 Apr 18. doi: 10.1002/cncr.31407.
    PubMed     Text format     Abstract available


    March 2018
  21. HU J, Bao C, Gao J, Guan X, et al
    Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31318.
    PubMed     Text format     Abstract available


    January 2018
  22. ZIMMARO LA, Sephton SE, Siwik CJ, Phillips KM, et al
    Depressive symptoms predict head and neck cancer survival: Examining plausible behavioral and biological pathways.
    Cancer. 2018 Jan 22. doi: 10.1002/cncr.31109.
    PubMed     Text format     Abstract available


  23. XIAO R, Ward MC, Yang K, Adelstein DJ, et al
    Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality.
    Cancer. 2018 Jan 9. doi: 10.1002/cncr.31213.
    PubMed     Text format     Abstract available


  24. RAZZAGHI H, Saraiya M, Thompson TD, Henley SJ, et al
    Five-year relative survival for human papillomavirus-associated cancer sites.
    Cancer. 2018;124:203-211.
    PubMed     Text format     Abstract available


    December 2017
  25. DAHLSTROM KR, Anderson KS, Field MS, Chowell D, et al
    Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
    Cancer. 2017;123:4886-4894.
    PubMed     Text format     Abstract available


  26. CHIN RI, Rao YJ, Hwang MY, Spencer CR, et al
    Comparison of unilateral versus bilateral intensity-modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil.
    Cancer. 2017;123:4594-4607.
    PubMed     Text format     Abstract available


    November 2017
  27. ALI SM, Ross JS, Wang K
    Reply to Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assays.
    Cancer. 2017 Nov 22. doi: 10.1002/cncr.31132.
    PubMed     Text format    


  28. LUI VWY, To KF, Lo KW
    Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assays.
    Cancer. 2017 Nov 22. doi: 10.1002/cncr.31131.
    PubMed     Text format    


  29. PRINTZ C
    First person: Maura L. Gillison, MD, PhD: The researcher who found the link between the human papillomavirus and head and neck cancers continues to lead new discoveries in the field.
    Cancer. 2017;123:4307.
    PubMed     Text format    


  30. LANG KUHS KA, Kreimer AR, Trivedi S, Holzinger D, et al
    Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Cancer. 2017;123:4382-4390.
    PubMed     Text format     Abstract available


  31. GUPTA A, Sonis ST, Schneider EB, Villa A, et al
    Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31095.
    PubMed     Text format     Abstract available


  32. HOBAN CW, Beesley LJ, Bellile EL, Sun Y, et al
    Individualized outcome prognostication for patients with laryngeal cancer.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31087.
    PubMed     Text format     Abstract available


    October 2017
  33. HUANG WB, Chan JYW, Liu DL
    Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: Multicenter study from an endemic area in Southern China.
    Cancer. 2017 Oct 26. doi: 10.1002/cncr.31031.
    PubMed     Text format     Abstract available


  34. BURTNESS B
    The tumor genome in human immunodeficiency virus-related head and neck cancer: Exploitable targets?
    Cancer. 2017 Oct 20. doi: 10.1002/cncr.31059.
    PubMed     Text format    


  35. GLEBER-NETTO FO, Zhao M, Trivedi S, Wang J, et al
    Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Cancer. 2017 Oct 20. doi: 10.1002/cncr.31063.
    PubMed     Text format     Abstract available


  36. NELSON RA, Lai LL
    Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Cancer. 2017;123:4013-4021.
    PubMed     Text format     Abstract available


  37. CAPARROTTI F, Huang SH, Lu L, Bratman SV, et al
    Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Cancer. 2017;123:3691-3700.
    PubMed     Text format     Abstract available


    September 2017
  38. SACCO AG, Cohen EE
    Serum antibodies open the door to prediction and prognostication in human papillomavirus-related head and neck cancer.
    Cancer. 2017 Sep 26. doi: 10.1002/cncr.30970.
    PubMed     Text format    


    August 2017
  39. ALBERGOTTI WG, Jordan J, Anthony K, Abberbock S, et al
    A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
    Cancer. 2017;123:3132-3140.
    PubMed     Text format     Abstract available


  40. ROBIN TP, Jones BL, Gordon OM, Phan A, et al
    A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.
    Cancer. 2017;123:3040-3049.
    PubMed     Text format     Abstract available


    April 2017
  41. D'SOUZA G, Robbins HA
    Sexual and relationship health among survivors of oropharyngeal or oral cavity squamous cell carcinoma.
    Cancer. 2017;123:1092-1094.
    PubMed     Text format    


    March 2017
  42. SINHA P, Haughey BH, Kallogjeri D, Spitznagel EL, et al
    The role of postoperative chemoradiation for oropharyngeal carcinoma: A critical appraisal revisited.
    Cancer. 2017;123:887-888.
    PubMed     Text format    


    January 2017
  43. COOPER JS, Fortpied C, Gregoire V, Le QT, et al
    The role of postoperative chemoradiation for oropharynx carcinoma: A critical appraisal revisited.
    Cancer. 2017;123:12-16.
    PubMed     Text format    


  44. COLLINS GS, Le Manach Y
    Nomograms need to be presented in full.
    Cancer. 2017;123:177-178.
    PubMed     Text format    


  45. CHOI HC, Xu W, Lee AW
    Reply to Nomograms need to be presented in full.
    Cancer. 2017;123:178-179.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: